Initially, the meta-analysis indicated a significant association of the ERCC1 rs11615 polymorphism with lung cancer under the homozygous model with moderate corresponding among-study heterogeneity (I2 = 22.8%, P = 0.01). Here, ERCC1 is linked to lung carcinoma.